GISF, Covid-19 Vaccine Benchmarking Survey

GISF is conducting a benchmarking survey related to the covid-19 vaccine roll out and return-to-office plans. This survey is open to GISF members and network members to complete. The term return-to-office in this survey is used to describe a return to operating in office facilities.

Question Title

* 1. I am a...

GISF member (click here for a list of member organizations)

GISF network (non-members)

Other

Question Title

* 2. What best describes your role?

Security

Programs

Other

Question Title

* 3. At which level does your role sit?

HQ / Global

Regional

Country

Question Title

* 4. Does your organization have a return-to office policy and or guidance?

Yes

Still considering

Question Title

* 5. Has your organization surveyed staff on preferences for return-to-office strategies?

Yes

Question Title

* 6. What is the return-to-office status of your organization’s overall portfolio? (check all that apply)

All offices at all levels are open now

All offices re-opening gradually per jurisdictional regulation

Staff will have the option to return to in-office working

Staff will be required to return once offices are partially or fully open

Some offices are partly open

Other (please specify)

Question Title

* 7. Who are the key decision makers in your organization for return-to-work plans? (ex. HR, Security, CEO etc..)

Security

Programs

CEO/Executive level

Other (please specify)

Question Title

* 8. Is your organization developing a policy around Covid-19 vaccines?

Yes

Still considering

Question Title

* 9. Are you planning to make vaccination a requirement for return to office?

Yes

Still considering

Question Title

* 10. If Yes or still considering on having a vaccine policy: becoming covid-19 vaccinated is

Recommended

Required

Not required

Other (please specify)

Question Title

* 11. If yes or still considering on having a vaccine policy/guidance: Are contingencies being considered for staff who are unwilling, hesitant and or unable to take a covid-19 vaccine?

Yes

Still considering

Question Title

* 12. Are you considering vaccination as a requirement for staff travel?

Yes

Still considering

Question Title

* 13. If considering vaccination as a requirement, how is your organization planning to accommodate government and other jurisdictional regulations including financially (ex. Mandated quarantines, testing, vaccines)?

Organization will cover any incurred covid-19 related costs

Organization will cover some incurred covid-19 related costs

Other (please specify)

GISF, Covid-19 Vaccine Benchmarking Survey

Question Title

* 1. I am a...

Question Title

* 2. What best describes your role?

Question Title

* 3. At which level does your role sit?

Question Title

* 4. Does your organization have a return-to office policy and or guidance?

Question Title

* 5. Has your organization surveyed staff on preferences for return-to-office strategies?

Question Title

* 6. What is the return-to-office status of your organization’s overall portfolio? (check all that apply)

Question Title

* 7. Who are the key decision makers in your organization for return-to-work plans? (ex. HR, Security, CEO etc..)

Question Title

* 8. Is your organization developing a policy around Covid-19 vaccines?

Question Title

* 9. Are you planning to make vaccination a requirement for return to office?

Question Title

* 10. If Yes or still considering on having a vaccine policy: becoming covid-19 vaccinated is

Question Title

* 11. If yes or still considering on having a vaccine policy/guidance: Are contingencies being considered for staff who are unwilling, hesitant and or unable to take a covid-19 vaccine?

Question Title

* 12. Are you considering vaccination as a requirement for staff travel?

Question Title

* 13. If considering vaccination as a requirement, how is your organization planning to accommodate government and other jurisdictional regulations including financially (ex. Mandated quarantines, testing, vaccines)?

Question Title

* 14. What guidance, if any, are you giving to country offices who may not have access to a covid-19 vaccine for an extended period?

Question Title

* 15. What if any are your concerns about the vaccine rollout impacting your organizations operations?

Question Title

* 16. How is your organisation addressing vaccine exemptions, such as religious or medical ?

Question Title

* 17. Any additional comments you wish to note about return to office/ vaccine roll out?